Alembic Pharmaceuticals has informed that it enclosed a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter and half year ended 30th September, 2026 received from MUFG lntime India (Formerly known as Link lntime India), Registrar and Share Transfer Agent of the Company.
The above information is a part of company’s filings submitted to BSE.